Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yanrui Deng"'
Autor:
Simin Zhang, Jiahui Huang, Ligang Zhang, Jiangtao Gu, Qifang Song, Yaxiong Cai, Jiangchuan Zhong, Hui Zhong, Yanrui Deng, Wenhui Zhu, Jianfu Zhao, Ning Deng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Angiogenesis is considered one of the hallmarks of cancer and plays a critical role in the development of tumor. Fibroblast growth factor 2 (FGF-2) is a member of the FGF family and participates in excessive cancer cell proliferation and tumor angiog
Externí odkaz:
https://doaj.org/article/79fcf9cce77f4eae91e6a05f342fb717
Autor:
Ligang Zhang, Yanrui Deng, Yinmei Zhang, Chunyan Liu, Simin Zhang, Wenhui Zhu, Yong Tang, Ning Deng
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Tumor angiogenesis is dependent on growth factors, and inhibition of their pathways is one of the promising strategies in cancer therapy. However, resistance to single pathway has been a great concern in clinical trials so that it necessitates multip
Externí odkaz:
https://doaj.org/article/5d89a2f49b6a4f928e69afe252d78363
Publikováno v:
The Journal of Biochemistry. 165:487-495
The human fibroblast growth factor-2 (FGF-2) highly expressed in tumours is an important factor to promote tumour angiogenesis and lymphangiogenesis. A disulphide-stabilized diabody (ds-Diabody) could specifically target FGF-2 and show its advantages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff6a3696b7dacecd46bbdcd2862ffd0b
https://doi.org/10.1093/jb/mvy122
https://doi.org/10.1093/jb/mvy122
Autor:
Jiangchuan Zhong, Wenhui Zhu, Jiangtao Gu, Simin Zhang, Jiahui Huang, Jianfu Zhao, Ning Deng, Yanrui Deng, Yaxiong Cai, Qifang Song, Hui Zhong, Ligang Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Angiogenesis is considered one of the hallmarks of cancer and plays a critical role in the development of tumor. Fibroblast growth factor 2 (FGF-2) is a member of the FGF family and participates in excessive cancer cell proliferation and tumor angiog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c60886580afad8a177969f65f2db0d6d
https://www.frontiersin.org/articles/10.3389/fonc.2021.585457/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.585457/full
Publikováno v:
Protein expression and purification. 174
The recombinant multi-epitope vaccine called VBP3 is designed to suppress tumor growth and angiogenesis through targeting both basic fibroblast growth factor (bFGF) and vascular endothelial growth factor A (VEGFA). We are aiming to produce VBP3 vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70138aa2bc4d6fc57ff2280d8e3b8d31
https://pubmed.ncbi.nlm.nih.gov/32360598
https://pubmed.ncbi.nlm.nih.gov/32360598
Autor:
Ruiqiang Weng, Ligang Zhang, Yanrui Deng, Qing Zhang, Hui Liang, Zhitao Wan, Likuan Xiong, Lei Pan, Ning Deng, Xuejun Lao
Publikováno v:
International Journal of Peptide Research and Therapeutics. 23:469-479
Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) play a critical role in tumor-associated angiogenesis and have become the targets of anti-tumor therapy. The BALB/c mice were immunized with VEGF/bFGF complex peptide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80cecc15d5ca3544ca9732f66b72896e
https://doi.org/10.1007/s10989-017-9579-3
https://doi.org/10.1007/s10989-017-9579-3
Autor:
Haowu Jiang, Likuan Xiong, Ning Deng, Jinxia Zhang, Yunfei Yu, Jiangchuan Zhong, Xuejun Lao, Yiye Liang, Yaxiong Cai, Yanrui Deng
Publikováno v:
Cancer Science
Cancer Sci
Cancer Sci
Fibroblast growth factor-2 (FGF-2) is one of the most important angiogenic factors to promote tumor growth, progression and metastasis. Neutralizing antibodies against FGF-2 may suppress the growth of tumor cells by blocking the FGF-2 signaling pathw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c5587c515190547c86b1f8afec4b792
https://doi.org/10.1111/cas.12981
https://doi.org/10.1111/cas.12981
Autor:
Jinxia Zhang, Jiangchuan Zhong, Shuange Yao, Yaxiong Cai, Yanrui Deng, Haowu Jiang, Ning Deng
Publikováno v:
Oncotarget
// Yaxiong Cai 1, * , Shuange Yao 1, * , Jiangchuan Zhong 1, * , Jinxia Zhang 1 , Haowu Jiang 1 , Yanrui Deng 1 , Ning Deng 1 1 Guangdong Province Key Laboratory of Molecular Immunology and Antibody Engineering, College of Bioscience and Technology i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50b7c6d353d850790eb28720012c0d6
https://pubmed.ncbi.nlm.nih.gov/28423625
https://pubmed.ncbi.nlm.nih.gov/28423625